Health & Wellness Today New York
SEE OTHER BRANDS

Get your fresh news on health and wellness in New York

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on September 16, 2025

Senior Care Expert Todd Putzig Explains Why In-Home Help Goes Beyond Medical Care for HelloNation
USA Vascular Centers Urges Public to Prioritize Vascular Health During PAD Awareness Month
Chiropractic Expert Dr. Holly Potter Shares Pillow Support Advice for Side and Stomach Sleepers in HelloNation
The Brookbush Institute Publishes a NEW Glossary Term: 'Case-control Study'
Out for Undergrad(O4U) Welcomes Board Director Sophie Tahiri
Paragon Physical Therapy Recognized as Top Physical & Occupational Therapy Business of the Year for 2025
United Hospital Fund Analysis Highlights Impact of Changing Climate on Health, Safety, & Livelihoods of NYers/Americans
New Article Highlights Relationship Between Women and Dental Disease
Creative Diagnostics Announces Enterovirus Mouse Model to Accelerate Drug and Vaccine Development
RW3 CultureWizard Releases 2025 Corporate Culture Insights Survey Results at Sept. 17 Webinar
Westchester Plastic Surgeon Featured in New York Times as 2025 Super Doctor®
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
NPF Invites New York to Take ACTION for Psoriatic Disease
CPA Imaging Celebrates Grand Opening of Premier Concierge Medical Imaging Center in Midtown Manhattan
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak
Kane Biotech Completes U.S. FDA 510(k) Submission for revyve® Antimicrobial Wound Cleanser
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions